Efficacy of Two Doses of Duloxetine & Amitriptyline in Interstitial Lung Disease-related Cough
Status:
Recruiting
Trial end date:
2022-12-30
Target enrollment:
Participant gender:
Summary
This research study is evaluating the effectiveness of escalating doses of Amitriptyline and
Duloxetine in reducing cough frequency in patients with interstitial lung disease
(ILD)-related cough.
Phase:
Phase 2
Details
Lead Sponsor:
Mayo Clinic
Treatments:
Amitriptyline Amitriptyline, perphenazine drug combination Duloxetine Hydrochloride